Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radioactive 'Seek and Destroy' drug targets advanced prostate cancer

NCT ID NCT04868604

Recruiting now Disease control Sponsor: Clarity Pharmaceuticals Ltd Source: ClinicalTrials.gov ↗

Summary

This study is testing a new two-step treatment for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. First, a radioactive scanning drug finds the cancer spots. Then, a related radioactive treatment drug is given to target and damage those specific cancer cells. The main goals are to find a safe and effective dose and see if it shrinks tumors or lowers PSA levels.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BAMF Health

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

    Contact

  • East Jefferson General Hospital

    NOT_YET_RECRUITING

    River Ridge, Louisiana, 70123, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact

  • Stanford Cancer Institute

    RECRUITING

    Stanford, California, 94305, United States

    Contact

    Contact

  • Washington University School of Medicine at Barnes-Jewish Hospital

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

  • Weill Cornell Medicine at New York-Presbyterian

    RECRUITING

    New York, New York, 10021, United States

    Contact

  • XCancer

    RECRUITING

    Omaha, Nebraska, 68130, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATIC NEOPLASMS, CASTRATION-RESISTANT